Disciplinary Committee
The Disciplinary Committee of the Royal Pharmaceutical Society met on Monday 20, Tuesday 21, Wednesday 22 and Thursday 23 August 2007 and heard the following inquiries, under Statutory Committee rules (as provided for in the Pharmacists and Pharmacy Technicians Order 2007):
1. Following an inquiry into a complaint by the Council of the Society
against Adegboyega Bolarinwa Claudius Salako (registration number 66018),
the committee adjourned to resume the inquiry at a later date.
2. Following an inquiry into a complaint by the Council of the Society
against Mark Garry Browne (registration number 92589), the committee
directed the removal of Mr Browne’s name from the Register. The
committee found proved the Council’s allegation that the taking
of ampoules of oxycodone 10mg from patient returns for his own use; the
taking of a 30mg ampoule of diamorphine from patient returns for his
own use; and the taking of a 300ml bottle of Oramorph solution 10mg/5ml
for his own use, amounted to misconduct. Under Section 11 of the Pharmacy
Act 1954, the direction to remove Mr Browne’s name from the Register
is not to take effect until the expiration of a period of three months
from the date on which notice of removal was given or in a case where
an appeal has been brought against the direction, until the appeal is
determined or withdrawn.
3. Following an inquiry into a complaint by the Council of the Society
against Sunil Paul Khanna (registration number 75526) and Anil
Paul Khanna (registration number 75094), the committee adjourned to deliver their
determination on 31 August 2007.
Fitness to Practise
Committees Secretariat |
The
Pharmaceutical Journal